The tumor antigen chondroitin sulfate proteoglycan 4 (CSPG4) appears to be a useful biomarker to identify melanoma cells and an attractive target to apply antibody-based immunotherapy for the treatment of melanoma. Here we described the reverse transcription-polymerase chain reaction (RT-PCR) method and the immunohistochemical (IHC) staining method to detect the expression of CSPG4 in melanoma cells and tissues. © Springer Science+Business Media New York 2014.
CITATION STYLE
Wang, Y., Sabbatino, F., Wang, X., & Ferrone, S. (2014). Detection of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma. Methods in Molecular Biology, 1102, 523–535. https://doi.org/10.1007/978-1-62703-727-3_28
Mendeley helps you to discover research relevant for your work.